PCV67 PROJECTED COST SAVINGS TO THIRD PARTY PAYERS FOR THE YEAR FOLLOWING GENERIC SIMVASTATIN AVAILABILITY IN USA
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63682-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63682-0/fulltext
Title :
PCV67 PROJECTED COST SAVINGS TO THIRD PARTY PAYERS FOR THE YEAR FOLLOWING GENERIC SIMVASTATIN AVAILABILITY IN USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63682-0&doi=10.1016/S1098-3015(10)63682-0
First page :
Section Title :
Open access? :
No
Section Order :
533